|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jass JR, Sobin LH and Watanabe H: The
World Health Organization's histologic classification of
gastrointestinal tumors. A commentary on the second edition.
Cancer. 66:2162–2167. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Waddell T, Verheij M, Allum W, Cunningham
D, Cervantes A and Arnold D: European Society for Medical Oncology
(ESMO); European Society of Surgical Oncology (ESSO); European
Society of Radiotherapy and Oncology (ESTRO): Gastric cancer:
ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis,
treatment and follow-up. Eur J Surg Oncol. 40:584–591. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tomasello G, Ghidini M, Liguigli W, Ratti
M, Toppo L and Passalacqua R: Targeted therapies in gastric cancer
treatment: Where we are and where we are going. Invest New Drugs.
34:378–393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roukos DH: Current status and future
perspectives in gastric cancer management. Cancer Treat Rev.
26:243–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Demaria S, Pikarsky E, Karin M, Coussens
LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo
E, et al: Cancer and inflammation: Promise for biologic therapy. J
Immunother. 33:335–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Solinas G, Germano G, Mantovani A and
Allavena P: Tumor-associated macrophages (TAM) as major players of
the cancer-related inflammation. J Leukoc Biol. 86:1065–1073. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lou Y, Diao L, Cuentas ER, Denning WL,
Chen L, Fan YH, Byers LA, Wang J, Papadimitrakopoulou VA, Behrens
C, et al: Epithelial-mesenchymal transition is associated with a
distinct tumor microenvironment including elevation of inflammatory
signals and multiple immune checkpoints in lung adenocarcinoma.
Clin Cancer Res. 22:3630–3642. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Markowitz GJ, Michelotti GA, Diehl AM and
Wang XF: Inflammatory models drastically alter tumor growth and the
immune microenvironment in hepatocellular carcinoma. Sci Bull
(Beijing). 60:762–772. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanguinetti A, Santini D, Bonafè M,
Taffurelli M and Avenia N: Interleukin-6 and pro inflammatory
status in the breast tumor microenvironment. World J Surg Oncol.
13:1292015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishizuka M, Nagata H, Takagi K, Iwasaki Y,
Shibuya N and Kubota K: Clinical significance of the C-reactive
protein to albumin ratio for survival after surgery for colorectal
cancer. Ann Surg Oncol. 23:900–907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C,
Jin Y, Zhou YX, Wang DS, He MM, Bai L, et al: A novel
inflammation-based prognostic score in esophageal squamous cell
carcinoma: The C-reactive protein/albumin ratio. BMC Cancer.
15:3502015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H and Matsushima M:
The C-reactive protein/albumin ratio, a novel inflammation-based
prognostic score, predicts outcomes in patients with hepatocellular
carcinoma. Ann Surg Oncol. 22:803–810. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Shao Y, Fan M, Zhuang Q, Wang K,
Cao W, Xu X and He X: Prognostic significance of preoperative
C-reactive protein: Albumin ratio in patients with clear cell renal
cell carcinoma. Int J Clin Exp Pathol. 8:14893–14900.
2015.PubMed/NCBI
|
|
18
|
Haruki K, Shiba H, Shirai Y, Horiuchi T,
Iwase R, Fujiwara Y, Furukawa K, Misawa T and Yanaga K: The
C-reactive protein to albumin ratio predicts long-term outcomes in
patients with pancreatic cancer after pancreatic resection. World J
Surg. 40:2254–2260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim HS and Ku JH: Systemic inflammatory
response based on neutrophil-to-lymphocyte ratio as a prognostic
marker in bladder cancer. Dis Markers. 2016:83452862016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu G, Yao Y, Bai C, Zeng J, Shi D, Gu X,
Shi X and Song Y: Combination of platelet to lymphocyte ratio and
neutrophil to lymphocyte ratio is a useful prognostic factor in
advanced non-small cell lung cancer patients. Thorac Cancer.
6:275–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pistelli M, De Lisa M, Ballatore Z,
Caramanti M, Pagliacci A, Battelli N, Ridolfi F, Santoni M,
Maccaroni E, Bracci R, et al: Pre-treatment neutrophil to
lymphocyte ratio may be a useful tool in predicting survival in
early triple negative breast cancer patients. BMC Cancer.
15:1952015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bazzi WM, Tin AL, Sjoberg DD, Bernstein M
and Russo P: The prognostic utility of preoperative
neutrophil-to-lymphocyte ratio in localized clear cell renal cell
carcinoma. Can J Urol. 23:8151–8154. 2016.PubMed/NCBI
|
|
23
|
Williams KA, Labidi-Galy SI, Terry KL,
Vitonis AF, Welch WR, Goodman A and Cramer DW: Prognostic
significance and predictors of the neutrophil-to-lymphocyte ratio
in ovarian cancer. Gynecol Oncol. 132:542–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mao MJ, Wei XL, Sheng H, Wang XP, Li XH,
Liu YJ, Xing S, Huang Q, Dai SQ and Liu WL: Clinical significance
of preoperative albumin and globulin ratio in patients with gastric
cancer undergoing treatment. Biomed Res Int. 2017:30832672017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Budczies J, Klauschen F, Sinn BV, Győrffy
B, Schmitt WD, Darb-Esfahani S and Denkert C: Cutoff Finder: A
comprehensive and straightforward Web application enabling rapid
biomarker cutoff optimization. PLoS One. 7:e518622012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamamoto M, Kurokawa Y, Miyazaki Y, Makino
T, Takahashi T, Yamasaki M, Nakajima K, Takiguchi S, Mori M and
Doki Y: Usefulness of preoperative plasma fibrinogen versus other
prognostic markers for predicting gastric cancer recurrence. World
J Surg. 40:1904–1909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen Y, Qu H, Jian M, Sun G and He Q: High
level of serum AFP is an independent negative prognostic factor in
gastric cancer. Int J Biol Markers. 30:e387–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deng K, Yang L, Hu B, Wu H, Zhu H and Tang
C: The prognostic significance of pretreatment serum CEA levels in
gastric cancer: A meta-analysis including 14651 patients. PLoS One.
10:e1241512015.
|
|
29
|
Li S, Xu X, Liang D, Tian G, Song S and He
Y: Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR)
and platelet-to-lymphocyte ratio (PLR) in patients with gastric
cancer. Zhonghua Zhong Liu Za Zhi. 36:910–915. 2014.(In Chinese).
PubMed/NCBI
|
|
30
|
Mohamed MM, El-Ghonaimy EA, Nouh MA,
Schneider RJ, Sloane BF and El-Shinawi M: Cytokines secreted by
macrophages isolated from tumor microenvironment of inflammatory
breast cancer patients possess chemotactic properties. Int J
Biochem Cell Biol. 46:138–147. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ye Y, Liu S, Wu C and Sun Z: TGFβ
modulates inflammatory cytokines and growth factors to create
premetastatic microenvironment and stimulate lung metastasis. J Mol
Histol. 46:365–375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu Y and Cao X: Immunosuppressive cells
in tumor immune escape and metastasis. J Mol Med (Berl).
94:509–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mocellin MC, Pastore e Silva Jde A,
Camargo Cde Q, Fabre ME, Gevaerd S, Naliwaiko K, Moreno YM, Nunes
EA and Trindade EB: Fish oil decreases C-reactive protein/albumin
ratio improving nutritional prognosis and plasma fatty acid profile
in colorectal cancer patients. Lipids. 48:879–888. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dobrzycka B, Mackowiak-Matejczyk B,
Terlikowska KM, Kulesza-Bronczyk B, Kinalski M and Terlikowski SJ:
Serum levels of IL-6, IL-8 and CRP as prognostic factors in
epithelial ovarian cancer. Eur Cytokine Netw. 24:106–113.
2013.PubMed/NCBI
|
|
37
|
Steffens S, Al Ghazal A, Steinestel J,
Lehmann R, Wegener G, Schnoeller TJ, Cronauer MV, Jentzmik F,
Schrader M, Kuczyk MA and Schrader AJ: High CRP values predict poor
survival in patients with penile cancer. BMC Cancer. 13:2232013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Szturmowicz M, Rudziński P, Kacprzak A,
Langfort R, Bestry I, Broniarek-Samson B and Orłowski T: Prognostic
value of serum C-reactive protein (CRP) and cytokeratin 19
fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in
surgically treated patients with non-small cell lung cancer.
Pneumonol Alergol Pol. 82:422–429. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Heneghan HM, Zaborowski A, Fanning M,
McHugh A, Doyle S, Moore J, Ravi N and Reynolds JV: Prospective
study of malabsorption and malnutrition after esophageal and
gastric cancer surgery. Ann Surg. 262:803–807. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ryan AM, Power DG, Daly L, Cushen SJ,
NíBhuachalla Ē and Prado CM: Cancer-associated malnutrition,
cachexia and sarcopenia: The skeleton in the hospital closet 40
years later. Proc Nutr Soc. 75:pp. 199–211. 2016, View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fairclough E, Cairns E, Hamilton J and
Kelly C: Evaluation of a modified early warning system for acute
medical admissions and comparison with C-reactive protein/albumin
ratio as a predictor of patient outcome. Clin Med (Lond). 9:30–33.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Sun X, Liu J, Kong P, Chen S, Zhan
Y and Xu D: Preoperative C-reactive protein/albumin ratio predicts
prognosis of patients after curative resection for gastric cancer.
Transl Oncol. 8:339–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Duan H, Zhang X, Wang FX, Cai MY, Ma GW,
Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, et al: Prognostic role of
neutrophil-lymphocyte ratio in operable esophageal squamous cell
carcinoma. World J Gastroenterol. 21:5591–5597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Croker BA, Lewis RS, Babon JJ, Mintern JD,
Jenne DE, Metcalf D, Zhang JG, Cengia LH, O'Donnell JA and Roberts
AW: Neutrophils require SHP1 to regulate IL-1β production and
prevent inflammatory skin disease. J Immunol. 186:1131–1139. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nozawa H, Chiu C and Hanahan D:
Infiltrating neutrophils mediate the initial angiogenic switch in a
mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA.
103:pp. 12493–12498. 2006, View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Brandau S, Moses K and Lang S: The kinship
of neutrophils and granulocytic myeloid-derived suppressor cells in
cancer: Cousins, siblings or twins? Semin Cancer Biol. 23:171–182.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hao S, Andersen M and Yu H: Detection of
immune suppressive neutrophils in peripheral blood samples of
cancer patients. Am J Blood Res. 3:239–245. 2013.PubMed/NCBI
|
|
48
|
Shi F, Shi M, Zeng Z, Qi RZ, Liu ZW, Zhang
JY, Yang YP, Tien P and Wang FS: PD-1 and PD-L1 upregulation
promotes CD8(+) T-cell apoptosis and postoperative recurrence in
hepatocellular carcinoma patients. Int J Cancer. 128:887–896. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu S, Lachapelle J, Leung S, Gao D,
Foulkes WD and Nielsen TO: CD8+ lymphocyte infiltration
is an independent favorable prognostic indicator in basal-like
breast cancer. Breast Cancer Res. 14:R482012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kim JH, Han DS, Bang HY, Kim PS and Lee
KY: Preoperative neutrophil-to-lymphocyte ratio is a prognostic
factor for overall survival in patients with gastric cancer. Ann
Surg Treat Res. 89:81–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Choi WJ, Cleghorn MC, Jiang H, Jackson TD,
Okrainec A and Quereshy FA: Preoperative neutrophil-to-lymphocyte
ratio is a better prognostic serum biomarker than
platelet-to-lymphocyte ratio in patients undergoing resection for
nonmetastatic colorectal cancer. Ann Surg Oncol 22 Suppl.
3:S603–613. 2015. View Article : Google Scholar
|
|
52
|
Zhou P, Erfani S, Liu Z, Jia C, Chen Y, Xu
B, Deng X, Alfáro JE, Chen L, Napier D, et al: CD151-α3β1 integrin
complexes are prognostic markers of glioblastoma and cooperate with
EGFR to drive tumor cell motility and invasion. Oncotarget.
6:29675–29693. 2015. View Article : Google Scholar : PubMed/NCBI
|
